Emerging Therapies and the Expanding Role of Pharmacists in the Care of Patients with Heart Failure
This Continuing Education activity is supported by an educational grant from Novartis Pharmaceutical Corporation.
This activity is supported by an educational grant from Novartis Pharmaceutical Corporation.
Carolyn Hempel, PharmD, BCPS
Clinical Assistant Professor
University at Buffalo School of Pharmacy
& Pharmaceutical Sciences
Buffalo General Medical Center
Buffalo, New York
Tracy Macaulay, PharmD, BCPS (AQ Cardiology), AACC
Director, Transitional Care Pharmacy Services
University of Kentucky Healthcare
Director of Cardiovascular Pharmacy Services
Gill Heart Institute
Assistant Adjunct Professor
University of Kentucky
After completing this continuing education program, the participant will be able to:
- Explain the clinical and economic burden of heart failure (HF).
- Examine the efficacy, safety, and potential role of emerging therapies for HF.
- Illustrate the overarching roles of health-system and community pharmacists as part of a multidisciplinary team for caring for patients with HF.
- Identify strategies that can help health-system and community pharmacists enhance transitions of care for patients with HF.
Type of activity:
: July 6, 2015
July 6, 2017
Estimated time to complete activity:
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-072-H01-P. The activity is available for CE credit through July 6, 2017.